The Effect of Chloroquine on the Apoptosis Induced by Cisplatin in Human Gastric Cancer BGC823 Cells

Abstract:

The aim of this study is to investigate the effects and mechanism of chloroquine (CQ) on the apoptosis induced by cisplatin in human gastric cancer BGC823 cells. MTT assay was used to detect the state of cell growth. The appearances of cellular apoptosis were detected by laser scanning confocal microscopy and light microscopy. The expressions of LC3 and p62 were detected by laser scanning confocal microscopy. MTT tests showed that the non-toxic dose of CQ could increase the inhibition rate of BGC823 cells induced by cisplatin. Under the light microscope, the ratio of apoptotic cells in the group treated with non-toxic dose of CQ combined with cisplatin was higher than that in the group treated with cisplatin alone. Hoechst33342 staining showed that the ratio of apoptotic cells in the combination group was higher than that in the cisplatin group. The expression and colocalization of LC3 and p62 proteins were significantly increased in the combination group. These results indicate that CQ can enhance the cell apoptosis induced by cisplatin in BGC823 cells, which is through the inhibition of autophagy.

• Periodical: Advanced Materials Research (Volumes 926-930)
• Pages: 1124-1127
• DOI: https://doi.org/10.4028/www.scientific.net/AMR.926-930.1124
• Online since: May 2014
• Authors: Zhen Xun Jin, Li Li Zhang, Yan Wang, Lin Chuan Zeng, Yang Yu, Shi Bing Liu, Xiao Jun Wang, Ye Xu*
• Keywords: Apoptosis, BGC823 Cells, Chloroquine, Cisplatin

References

[1] Muggia F. Platinum compounds 30 years after the introduction of cisplatin: implications for the treatment of ovarian cancer. Gynecol Oncol. 2009 Jan; 112(1): 275-81.

DOI: 10.1016/j.ygyno.2008.09.034

[2] Florea AM, Büsselberg D. Cisplatin as an anti-tumor drug: cellular mechanisms of activity, drug resistance and induced side effects. Cancers (Basel). 2011 Mar 15; 3(1): 1351-71.

DOI: 10.3390/cancers3011351

[3] Galluzzi L, Senovilla L, Vitale I, Michels J, Martins I, Kepp O, Castedo M, Kroemer G. Molecular mechanisms of cisplatin resistance. Oncogene. 2012 Apr 12; 31(15): 1869-83.

DOI: 10.1038/onc.2011.384

[4] Brozovic A, Ambriović-Ristov A, Osmak M. The relationship between cisplatin-induced reactive oxygen species, glutathione, and BCL-2 and resistance to cisplatin. Crit Rev Toxicol. 2010 Apr; 40(4): 347-59.

DOI: 10.3109/10408441003601836

[5] Song J, Qu Z, Guo X, Zhao Q, Zhao X, Gao L, Sun K, Shen F, Wu M, Wei L. Hypoxia-induced autophagy contributes to the chemoresistance of hepatocellular carcinoma cells. Autophagy. 2009 Nov; 5(8): 1131-44.

DOI: 10.4161/auto.5.8.9996

[6] Vazquez-Martin A, Oliveras-Ferraros C, Menendez JA. Autophagy facilitates the development of breast cancer resistance to the anti-HER2 monoclonal antibody trastuzumab. PLoS One. 2009 Jul 16; 4(7): e6251.

DOI: 10.1371/journal.pone.0006251

[7] Lim SC, Hahm KS, Lee SH, Oh SH. Autophagy involvement in cadmium resistance through induction of multidrug resistance-associated protein and counterbalance of endoplasmic reticulum stress WI38 lung epithelial fibroblast cells. Toxicology. 2010 Sep 30; 276(1): 18-26.

DOI: 10.1016/j.tox.2010.06.010

[8] Lamark T, Kirkin V, Dikic I, Johansen T. NBR1 and p.62 as cargo receptors for selective autophagy of ubiquitinated targets. Cell Cycle. 2009 Jul 1; 8(13): 1986-90.

DOI: 10.4161/cc.8.13.8892